262 related articles for article (PubMed ID: 23148090)
21. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
22. Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.
Argolini LM; Frontini G; Elefante E; Saccon F; Binda V; Tani C; Scotti I; Carli L; Gatto M; Esposito C; Gerosa M; Caporali R; Doria A; Messa P; Mosca M; Moroni G
J Nephrol; 2021 Apr; 34(2):389-398. PubMed ID: 32462476
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
Cortés-Hernández J; Torres-Salido MT; Medrano AS; Tarrés MV; Ordi-Ros J
Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
[TBL] [Abstract][Full Text] [Related]
25. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
Mok CC; Ho LY; Ying SKY; Leung MC; To CH; Ng WL
Ann Rheum Dis; 2020 Aug; 79(8):1070-1076. PubMed ID: 32448782
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
29. Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritis.
Tse KC; Tang CS; Lio WI; Lam MF; Chan TM
Lupus; 2006; 15(6):371-9. PubMed ID: 16830884
[TBL] [Abstract][Full Text] [Related]
30. Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis.
Tse KC; Tang CS; Lam MF; Yap DY; Chan TM
J Rheumatol; 2009 Jan; 36(1):76-81. PubMed ID: 19004041
[TBL] [Abstract][Full Text] [Related]
31. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?
Lenz O; Waheed AA; Baig A; Pop A; Contreras G
Clin J Am Soc Nephrol; 2013 Jan; 8(1):162-71. PubMed ID: 22917704
[TBL] [Abstract][Full Text] [Related]
32. Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study.
Yap DYH; Kwan LPY; Ma MKM; Mok MMY; Chan GCW; Chan TM
Nephrol Dial Transplant; 2019 Mar; 34(3):467-473. PubMed ID: 29509932
[TBL] [Abstract][Full Text] [Related]
33. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
34. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis.
Lee YH; Song GG
Z Rheumatol; 2024 Feb; 83(Suppl 1):140-147. PubMed ID: 37278824
[TBL] [Abstract][Full Text] [Related]
35. Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis.
Laskari K; Tzioufas AG; Antoniou A; Moutsopoulos HM
J Rheumatol; 2011 Jul; 38(7):1304-8. PubMed ID: 21498485
[TBL] [Abstract][Full Text] [Related]
36. Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection.
Krischock L; Gullett A; Bockenhauer D; Rees L; Trompeter RS; Marks SD
Pediatr Transplant; 2009 Jun; 13(4):475-81. PubMed ID: 18992054
[TBL] [Abstract][Full Text] [Related]
37. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population.
Mejía-Vilet JM; Córdova-Sánchez BM; Uribe-Uribe NO; Correa-Rotter R
Clin Rheumatol; 2016 Sep; 35(9):2219-27. PubMed ID: 27475791
[TBL] [Abstract][Full Text] [Related]
40. The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.
Baskin E; Ozen S; Cakar N; Bayrakci US; Demirkaya E; Bakkaloglu A
Pediatr Nephrol; 2010 Jan; 25(1):111-7. PubMed ID: 19727839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
